Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (Vascular Endothelial Growth Factor TrapA40)

Endocrinology

Volumn 142, Issue 7, 2001, Pages 3244-3254

  Wulff, Christine ^a   Wiegand, Stanley J ^b   Saunders, Philippa T K ^a   Scobie, Graeme A ^a   Fraser, Hamish M ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD31 ANTIGEN; FC RECEPTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP A40; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MONKEY; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

EID: 0034987872     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.7.8258     Document Type: Article

References (30)

1. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries
2. Angiogenesis in reproductive tissues
3. Gonadotropin-binding sites in the rhesus monkey ovary: Role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle
4. Vascular endothelial growth factor is expressed in rat corpus luteum
5. Vascular endotheliai growth factor messenger ribonucleic acid expression in the primate ovary
6. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
7. Increased expression of vascular endothelial growth permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: Potential roles in follicle rupture
8. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary
9. Vascular endothelial growth factor production in growing pig antral follicles
10. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
11. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
12. A40
13. The effects of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
14. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus)
15. Angiogenesis in the human corpus luteum: Localization and changes in angiopoietins, Tie-2, and vascular endothelial growth factor messenger ribonucleic acid
16. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
17. Signaling vascular morphogenesis and maintenance
18. Ovarian angiogenesis
19. Ovarian control of follicle development
20. Regulation of ovarian follicular development in primates: Facts and hypotheses
21. Expression of mouse ovarian insulin growth factor system components during follicular development and atresia
22. Cell signaling permeability and microvasculatory changes during antral follicle development in mammals
23. Temporal and topographic changes in DNA synthesis after induced follicular atresia
24. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
25. Suppression of luteal angiogenesis in the primate by neutralization of vascular endothelial growth factor
26. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
27. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
28. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction
29. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
30. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro